To assess the prevalence, practices, beliefs, and expectations of patients with rheumatic diseases in relation to the use of alternative therapies.
We conducted a cross-sectional survey of 300 consecutive patients with rheumatic diseases at 3 outpatient rheumatic disease clinics in Guadalajara, Mexico to evaluate the use of alternative therapies.
A face-to-face structured interview was administered by a trained assistant to evaluate the prevalence of use and patient beliefs, perceptions, and expectations in relation to alternative therapies.
Two hundred fifty patients (83%) had used a total of 1,386 alternative therapies (range 1-19) ; 203 (68%) patients had used alternative therapy in the previous 12 months.
Sixty-one percent received at least one alternative treatment before the first rheumatology consultation, but an additional 18% initiated these therapies after their initial contact with a rheumatologist at our clinics.
Only 66 (26%) of the patients using alternative therapy notified their rheumatologist about their use.
Thirty-six patients (14%) discontinued formal treatment at least on one occasion in order to receive alternative therapies, and only 8 (22%) notified their rheumatologist.
Alternative therapy practitioners recommended discontinuation of conventional therapy on 57% of the occasions when formal treatments were discontinued. (...)
Mots-clés Pascal : Polyarthrite rhumatoïde, Croyance, Efficacité traitement, Médecine parallèle, Traitement, Chimiothérapie, Epidémiologie, Prévalence, Mexique, Amérique Centrale, Amérique, Lupus érythémateux, Disséminé, Spondylarthropathie, Homme, Chronique, Système ostéoarticulaire pathologie, Rhumatisme inflammatoire, Immunopathologie, Maladie autoimmune, Peau pathologie, Tissu conjonctif pathologie, Maladie système
Mots-clés Pascal anglais : Rheumatoid arthritis, Belief, Treatment efficiency, Alternative medicine, Treatment, Chemotherapy, Epidemiology, Prevalence, Mexico, Central America, America, Lupus erythematosus, Disseminated, Spondylarthropathy, Human, Chronic, Diseases of the osteoarticular system, Inflammatory joint disease, Immunopathology, Autoimmune disease, Skin disease, Connective tissue disease, Systemic disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0530178
Code Inist : 002B15D. Création : 23/03/1999.